HAON Life Sciences: Funding, Investors & Team (Sep 2026)
It specializes in developing innovative cell therapies, with a primary focus on addressing neonatal brain injuries caused by hypoxic-ischemic encephalopathy (HIE). This condition, resulting from oxygen deprivation during or shortly after birth, is a leading cause of neonatal deaths and long-term neurological impairments, such as cerebral palsy and epilepsy.
HAON Life Sciences has raised $11.7M across 1 funding round on record, the most recent an undisclosed round of $11.7M announced in Apr 2025.
That round is above the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
HAON Life Sciences Company Profile and Key Stats
Latest funding round on record: Apr 2025.
HAON Life Sciences Funding Rounds
HAON Life Sciences Founders and Leadership Team
Contact details for the HAON Life Sciences team: 1 of 1 has an email address on file.
Start 14-day free trial →HAON Life Sciences Funding Compared to Other Biotechnology Research Startups
HAON Life Sciences' latest round of $11.7M is above the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like HAON Life Sciences in Biotechnology Research and Dublin
Companies Similar to HAON Life Sciences
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive…
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Native Labs is a platform using AI to improve efficiency and scalability in the manufacturing of Cell and…
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have…
The Polari Group feels that the sexual health and wellness industry should be inclusive and that the future…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
Fresh Inset Vision aims to conserve fresh produce resources by implementing advanced Vidre+ technology that…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
HAON Life Sciences Funding FAQs
What does HAON Life Sciences do?
It specializes in developing innovative cell therapies, with a primary focus on addressing neonatal brain injuries caused by hypoxic-ischemic encephalopathy (HIE). This condition, resulting from oxygen deprivation during or shortly after birth, is a leading cause of neonatal deaths and long-term neurological impairments, such as cerebral palsy and epilepsy.
How much funding has HAON Life Sciences raised?
HAON Life Sciences has raised $11.7M across 1 round on record. The most recent is an undisclosed round of $11.7M announced in Apr 2025.
When did HAON Life Sciences last raise funding?
HAON Life Sciences' most recent funding round on record is an undisclosed round of $11.7M, announced in Apr 2025.
Who founded HAON Life Sciences?
FundedIQ lists Mark Oneill (Founder) at HAON Life Sciences.
Where is HAON Life Sciences headquartered?
HAON Life Sciences is based in Dublin, Ireland.
How many employees does HAON Life Sciences have?
HAON Life Sciences is in the 1-10 employee band.
How does HAON Life Sciences' funding compare to other Biotechnology Research startups?
HAON Life Sciences' latest round of $11.7M is above the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's HAON Life Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for HAON Life Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.